Related Experiment Videos
Molecular genetic markers in lymphoproliferative disorders
1Department of Laboratory Medicine, Ottawa Civic Hospital, Ontario, Canada.
Clinical Biochemistry
|February 1, 1989
Summary
Antibody diversity arises from gene shuffling in B and T cells, creating unique receptors. This process, detectable via Southern blot, aids in identifying cell origins and understanding oncogene involvement in lymphomas and leukemias.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- B and T cells generate unique antigen receptors (immunoglobulin and T cell receptor) through gene shuffling.
- This genetic diversity is crucial for adaptive immunity and is unique to each cell.
- Antibody diversity mechanisms are relatively new but have significant implications in biology and medicine.
Purpose of the Study:
- To explore the genetic mechanisms behind antibody diversity.
- To demonstrate how Southern blot hybridization can identify B or T cell origin and clonality.
- To investigate the link between oncogene activity, chromosomal translocations, and lymphoid malignancies.
Main Methods:
- Gene shuffling and Southern blot hybridization were used to analyze lymphocyte populations.
- Investigated the association of oncogenes (e.g., c-myc) with chromosomal translocations in lymphomas.
- Searched for novel proto-oncogenes in lymphomas with characteristic translocations.
Main Results:
- Southern blot analysis can distinguish B cell origin (immunoglobulin gene rearrangements) from T cell origin (T cell receptor gene rearrangements).
- It can also determine if a lymphocyte population is monoclonal (derived from a single progenitor).
- Established oncogenes like c-myc are linked to translocations near immunoglobulin enhancers in certain lymphomas.
Conclusions:
- Gene rearrangement is fundamental to generating diverse B and T cell receptors.
- Southern blot is a valuable tool for immunophenotyping and clonality assessment of lymphocytes.
- Chromosomal translocations involving oncogenes are implicated in the pathogenesis of lymphomas and leukemias, guiding the search for new oncogenes.